Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
12/09/2009 | CN101600719A Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol |
12/09/2009 | CN101600460A Ultrasound microbubble mediated genes delivery system |
12/09/2009 | CN101600426A Isosorbide mononitrate derivatives for the treatment of intestinal disorders |
12/09/2009 | CN101600425A Isosorbide mononitrate derivatives for the treatment of ocular hypertension |
12/09/2009 | CN101600423A Composition for amelioration/prevention of adverse side effect in steroid therapy |
12/09/2009 | CN101600421A Use of erss selective ligands for treating acute lung injuries |
12/09/2009 | CN101597337A Conjugate of hydroxyalkyl starch and an active agent |
12/09/2009 | CN101597294A 3-aminoalkaneacylamino-rutaecarpine and 3-aminoalkaneacylamino-7,8-dehydrorutaecarpine derivative |
12/09/2009 | CN101597280A Compound used as seven-pass transmembrane protein and based on sag structure |
12/09/2009 | CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
12/09/2009 | CN101596265A Traditional Chinese medicine compound preparation for enhancing body fatigue resistance |
12/09/2009 | CN101596261A Medicament for treating hydrocephalus and preparation method thereof |
12/09/2009 | CN101596260A Chinese patent medicine for treating epilepsy and postpartum epilepsy and preparation method thereof |
12/09/2009 | CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor |
12/09/2009 | CN101596184A Application of rosmarinic acid as peroxynitrite inhibitor |
12/09/2009 | CN100567489C Antiallergic agent and pharmaceutical use thereof |
12/09/2009 | CN100567488C Enhancement of virus-mediated DNA transfer |
12/09/2009 | CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives |
12/09/2009 | CN100567253C Novel succinate salt of O-demethyl-venlafaxine |
12/09/2009 | CN100567242C Hsp90 family protein inhibitors |
12/09/2009 | CN100566728C Method for extracting bitter buckwheat flavone in high purity |
12/09/2009 | CN100566723C Carbohydrase inhibitors derived from chestnut and use thereof |
12/09/2009 | CN100566719C Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients |
12/09/2009 | CN100566591C Bait used specially for atlantic trout |
12/08/2009 | US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide |
12/08/2009 | US7629468 Neuroprotectants, analgesics or anticonvulsants |
12/08/2009 | US7629456 Modified L-nucleic acid |
12/08/2009 | US7629381 Such as picropodophyllin, for the inhibition of the insulin-like growth factor-1 receptor; cancer, psoriasis, artherosclerosis and acromegaly |
12/08/2009 | US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
12/08/2009 | US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
12/08/2009 | US7629366 Aminoalcohol derivatives |
12/08/2009 | US7629363 Diaryl substituted pyridinones |
12/08/2009 | US7629362 2-pyridine carboxamide derivatives |
12/08/2009 | US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
12/08/2009 | US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors |
12/08/2009 | US7629341 Human ADAM-10 inhibitors |
12/08/2009 | US7629337 Chemokine receptor binding heterocyclic compounds |
12/08/2009 | US7629326 Chromosomal modification involving the induction of double-stranded DNA cleavage and homologous recombination at the cleavage site |
12/08/2009 | US7629321 Oligoribonucleotides and ribonucleases for cleaving RNA |
12/08/2009 | US7629318 Immunosuppressant compounds, methods and uses related thereto |
12/08/2009 | US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo |
12/08/2009 | US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
12/08/2009 | US7628983 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide |
12/08/2009 | CA2485916C Non-nucleoside reverse transcriptase inhibitors |
12/08/2009 | CA2482311C Furyl compounds |
12/08/2009 | CA2440744C Il-12 expression controlling agent |
12/08/2009 | CA2434829C New benzoylguanidine salt |
12/08/2009 | CA2422807C N-substituted benzothiophenesulfonamide derivatives |
12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
12/08/2009 | CA2422342C Novel amide derivatives and medicinal use thereof |
12/08/2009 | CA2415486C Pyramidine derivatives |
12/08/2009 | CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
12/08/2009 | CA2381801C Phosphonic acid derivative having inhibitory activity against carboxypeptidase b |
12/08/2009 | CA2375986C Substituted pyrazole compounds |
12/08/2009 | CA2374898C Pyrazinyl-piperazine compounds, their use and preparation |
12/08/2009 | CA2373183C Iminocyclitol inhibitors of hexoaminidase and glycosidase |
12/08/2009 | CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
12/08/2009 | CA2358289C Amide derivatives for antiangiogenic and/or antitumorigenic use |
12/08/2009 | CA2355075C Heteroaryl-cyclic acetals |
12/08/2009 | CA2340952C Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists |
12/08/2009 | CA2333475C Derivatives of pyrazolines, their preparation and their application as medicaments |
12/08/2009 | CA2315113C Pyridones as src family sh2 domain inhibitors |
12/08/2009 | CA2314613C Azolo triazines and pyrimidines |
12/08/2009 | CA2266584C Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
12/08/2009 | CA2263898C Composition and method for repairing neurological tissue |
12/03/2009 | WO2009146153A2 Manufacture, transport and delivery of material containing highly polarized nuclei |
12/03/2009 | WO2009145852A1 Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof |
12/03/2009 | WO2009145289A1 Inhibitor of analgesic tolerance |
12/03/2009 | WO2009145238A1 Immunomodulatory agent and use thereof |
12/03/2009 | WO2009145219A1 Therapeutic agent for alzheimer's disease |
12/03/2009 | WO2009145177A1 Donepezil-containing patch preparation and packaging thereof |
12/03/2009 | WO2009145171A1 Novel benzothiophene oxide derivative and salt thereof |
12/03/2009 | WO2009144961A1 Substituted carbinol compound having cyclic linker |
12/03/2009 | WO2009144933A1 Apoptosis inducer |
12/03/2009 | WO2009144577A2 Anionic polyamide functionalized by a tryptophan unit |
12/03/2009 | WO2009144278A2 USES OF CONGLUTIN-γ |
12/03/2009 | WO2009103218A8 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof |
12/03/2009 | WO2009032888A3 Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract |
12/03/2009 | US20090299268 Topical Aminolevulinic Acid-Photodynamic Therapy for the Treatment of Acne Vulgaris |
12/03/2009 | US20090298946 Local Anesthetic Deactivation |
12/03/2009 | US20090298939 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
12/03/2009 | US20090298936 Method for energizing human beings |
12/03/2009 | US20090298922 Aav transduction of muscle tissue |
12/03/2009 | US20090298921 Methods and compositions for use in homologous recombination |
12/03/2009 | US20090298876 Modulators of atp-binding cassette transporters |
12/03/2009 | US20090298873 Methods of reducing microbial resistance to drugs |
12/03/2009 | US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells |
12/03/2009 | US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators |
12/03/2009 | US20090298791 Combinations comprising epothilones and antimetabolites |
12/03/2009 | US20090298789 arresting heart of subject in need of heart surgery by exposing heart to effective amounts of a compound chosen from a potassium channel opener, a potassium channel agonist, an adenosine receptor agonist, and a local anaesthetic under conditions sufficient for heart to be arrested |
12/03/2009 | US20090298775 Method of measuring neprilysin activity |
12/03/2009 | US20090298762 Conjugates of biologically active proteins having a modified in vivo half-life |
12/03/2009 | US20090298743 Hydrophobic compositions containing reconstitution enhancer |
12/03/2009 | US20090298120 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof |
12/03/2009 | US20090297644 Herbal compositions for the treatment of diseases of the oral cavity |
12/03/2009 | US20090297641 Herbal compositions for the treatment of mucosal lesions |
12/03/2009 | US20090297598 Therapeutic combination |
12/03/2009 | US20090297597 Modified Release Ticlopidine Compositions |
12/03/2009 | US20090297591 Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds |